Enara Bio
An Oxford-based biotech company developing “cutting-edge” cancer treatments
Enara Bio has raised €29M across 1 funding round from 3 investors, most recently a Series B round in Oct 2024. Based in Oxford, UK; active in Healthtech. Data as of 28 Oct 2026.
Oxford, UKwww.enarabio.com ↗
Total raised
€29M
€29,441,073
Funding rounds
1
Investors
3
distinct backers
Active since
2024-10
latest 2024-10
Funding by year
EUR raised per yearEnara Bio — funding by year — interactive chart.
Data table
| Enara Bio — funding by year | |
|---|---|
| 2024 | €29M |
Signals
High confidenceRaise-next likelihood51
base rate 48% for Series B
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-10-03 | Series B | €29M | Francis Crick Institute,M Ventures,Pfizer Ventures | View deal → |